Medtronic Sponsors the Addario Lung Cancer Foundation’s “Simply the Best” Dinner and Gala

For further information or inquiries, please contact:

Julia Spiess Lewis
Perry Communications Group
[email protected]

Medtronic Sponsors the Addario Lung Cancer Foundation’s “Simply the Best” Dinner and Gala
ALCF’s Tenth Annual Fundraiser Celebrates Lung Cancer Survivors and the Researchers, Physicians and Clinicians Fighting for Better Diagnoses and Improved Treatments

SAN CARLOS, Calif. (November 12, 2015) — The Bonnie J. Addario Lung Cancer Foundation (ALCF) today announced Medtronic as a title sponsor for its tenth annual “Simply the Best” Dinner and Gala. Through the sponsorship, Medtronic is demonstrating its commitment to reduce lung cancer morbidity by improving early diagnosis, thereby leading to earlier, personalized treatment. The Gala is in San Francisco, Calif. on November 14, 2015.

“Medtronic’s research initiatives and diagnostic tool development are critical for accurate, early detection of lung cancer, the number one cancer killer in the U.S.,” said Bonnie J. Addario, founder of the ALCF and a stage 3B lung cancer survivor. “Together we are setting the stage for a new, personalized standard of care to improve outcomes for all lung cancer patients.”

Medtronic recently launched GenCut, a core biopsy system to retrieve tissue specimens from the lungs during a biopsy. The tool is a minimally invasive diagnostic approach, ensuring undamaged tissue for proper diagnosis and further genetic testing and molecular analysis. Historically, lung cancer diagnosis occurs at a later stage due to a lack of symptoms, reducing the chance for patient’s long-term survival. Medtronic’s diagnostic products lay the foundation for advanced, personalized therapies and drugs for lung cancer patients.

“We are at a critical time for lung cancer patients,” said Heather Hudnut Page, Vice President of Global Marketing, Medtronic. “Diagnostic and surgical technologies have advanced significantly and many patients are leading long, active and healthy lives after a lung cancer diagnosis, which was completely unheard of even a decade ago. Medtronic is honored to support the ALCF and its ongoing work to communicate the importance of early diagnosis and targeted treatments for patients diagnosed with lung cancer.”

While the understanding of the diagnosis and treatment of lung cancer has improved, lung cancer still accounts for more cancer deaths than breast, colon and prostate cancer combined. In 2015, an expected 221,200 new lung cancer diagnoses in the U.S. will lead to nearly 158,040 Americans to die of the disease.1 When diagnosed early, an estimated 85 percent of lung cancer cases appear at a more curable stage.3 Early detection and immediate treatment dramatically increases the typical long-term survival rate from 15 percent at five years2 to 88 percent at 10 years.3

For more information about the “Simply the Best” Dinner and Gala visit:

For more information about the ALCF please visit or follow us on Facebook or Twitter.

About the Bonnie J. Addario Lung Cancer Foundation
The Bonnie J. Addario Lung Cancer Foundation (ALCF) is one of the largest philanthropies (patient-founded, patient-focused, and patient-driven) devoted exclusively to eradicating Lung Cancer through research, early detection, education, and treatment. The Foundation’s goal is to work with a diverse group of physicians, organizations, industry partners, individuals, patients, survivors, and their families to identify solutions and make timely and meaningful change and turn lung cancer into a chronically managed disease by 2023. The ALCF was established on March 1, 2006 as a 501c(3) non-profit organization and has raised nearly $25 million for lung cancer research and related programs.

About Medtronic
Medtronic plc (, headquartered in Dublin, Ireland, is among the world’s largest medical technology, services and solutions companies — alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 85,000 people worldwide, serving physicians, hospitals and patients in more than 160 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

1 American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015.
2 The International Early Lung Cancer Action Program Investigators. N Engl J Med 2006; 355:1763-1771.
3 American Cancer Society: Cancer Facts & Figures 2014